Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utilizing genomic polymorphisms to personalize hepatitis C therapies.

Current opinion in organ transplantation - 1 Apr 2012

Rifai Muhamad Aly, Sabouni Mouhamed Amr

Abstract excerpt

PURPOSE OF REVIEW: The need for liver transplant due to the progression of hepatitis C virus (HCV) infection necessitates the consideration of antiviral treatment. Host genomic variations affect response to HCV treatment and predict the rates of adverse effects. Recently, multiple genomic polymorphisms were found to be critical in predicting treatment response as well as the rate of neuropsychiatric adverse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Depressive Disorder, Major
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Interferon-alpha

Share to Pharmacogenetics

Share to Ribavirin

Share to Viral Load

Source

Identifiers

PMID: 22414802
DOI: 10.1097/MOT.0b013e328351093b

Genes

IFNAR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utilizing genomic polymorphisms to personalize hepatitis C therapies.PMID 22414802Read ↗

Promoter polymorphisms of the interferon-alpha receptor gene and development of Interferon-induced depressive symptoms in patients with chronic hepatitis C: preliminary findings.Semantic proximity Read ↗

The role of pharmacogenetics in the treatment of chronic hepatitis C infection.Semantic proximity Read ↗

The role of genetic markers in hepatitis C virus therapy: a major step for individualized care.Semantic proximity Read ↗

A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.Semantic proximity Read ↗

Interferon-gamma (+874) T/A genotypes and risk of IFN-alpha-induced depression.Semantic proximity Read ↗

Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C.Semantic proximity Read ↗

Pharmacogenetics of hepatitis CSemantic proximity Read ↗

Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.Semantic proximity Read ↗

IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy.Semantic proximity Read ↗

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.Semantic proximity Read ↗

The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin.Semantic proximity Read ↗

RNA editing blood biomarkers for predicting mood alterations in HCV patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.